ANTENATAL PHENOBARBITAL IN THE PREVENTION OF NEONTAL INTRACRANIAL HEMORRHAGE

产前苯巴比妥预防新生儿颅内出血

• 批准号: 6115010
• 负责人: DAVID K STEVENSON
• 金额: $ 4.03万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6115010
• 关键词: cerebral hemorrhage; cerebral ischemia /hypoxia; chemoprevention; clinical research; embryo /fetus chemotherapy; female; human pregnant subject; human subject; infant mortality; mother /infant health care; neuropsychology; pediatrics; perinatal; phenobarbital; premature infant human

Examines if Phenobarbital administered antenatally to pregnant women </= 32 wks gestation who are expected to deliver within 24 hours, will reduce the incidence of intracranial hemorrhage and/or ischemic brain injury, reduce the mortality rate & reduce the incidence of neurodevelopmental sequelae in the preterm neonate.

检查孕妇产前是否服用苯巴比妥</= 妊娠32周，预计在24小时内分娩的孕妇， 降低颅内出血和/或脑缺血的发生率 伤害，降低死亡率和减少发病率 早产儿的神经发育后遗症。